BridgeBio Oncology Therapeutics Inc. (BBOT) vs Mobia Medical, Inc. Common Stock (MOBI)
A side-by-side comparison of BridgeBio Oncology Therapeutics Inc. and Mobia Medical, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.51HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
MOBI
Mobia Medical, Inc. Common Stock
$8.85HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — BBOT vs MOBI
growth of $100 · dividends reinvested · last 1yBBOT -56.8% (-56.8%/yr)MOBI -36.1% (-36.1%/yr)MOBI compounded faster over this window
BBOT MOBI
BBOT vs MOBI: by the numbers
- •MOBI is the larger company ($294M vs $281M market cap).
- •Both run net losses; BBOT's is the smaller (0.00% vs -145.12% net margin).
Metrics side by side
Valuation
| Metric | BBOT | MOBI |
|---|---|---|
| P/B ratio | 0.87 | 1.70 |
Profitability
| Metric | BBOT | MOBI |
|---|---|---|
| Gross margin | 0.00% | 81.07% |
| Operating margin | 0.00% | -144.71% |
| Net margin | 0.00% | -145.12% |
| ROE | -56.36% | N/A |
| ROIC | -61.10% | -122.21% |
Go deeper
Dig into the metrics
BridgeBio Oncology Therapeutics ROEMobia Medical, Inc. Common Stock ROEBridgeBio Oncology Therapeutics operating marginMobia Medical, Inc. Common Stock operating marginBridgeBio Oncology Therapeutics revenue growthMobia Medical, Inc. Common Stock revenue growthBridgeBio Oncology Therapeutics free cash flowMobia Medical, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.